Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort

Press/Media

Period	9 Nov 2021

Media coverage

Title	Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort
Media name/outlet	ASHPublications.org
Country/Territory	United States
Date	9/11/21
URL	https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2021005794/477889/Polatuzumab-vedotin-plus-bendamustine-and
Persons	Tae Min Kim